
Rod James
A company subject to a secondaries transaction could have at least five layers of leverage acting on it, from LBO debt up to a fund-level capital call facility. We investigate the test posed by the coronavirus to these layers, each with their own dynamics.
An apparent flurry of dealflow doesn’t mean they will all get across the line.
The London-based lender is working alongside a 'significant' American institutional investor, sister title PEI understands.
An overhang of LPs wanting to sell stakes in funds could delay transfers in order to conform with publicly traded partnership rules.
GP-led processes were used to isolate top performing assets during the bull market, so why not the opposite now?
The limited partner body’s guidance on GP-led fund restructurings is designed to create an industry standard for the execution of these deals, but how effective has it been in practice?
Although public market volatility doesn't have to weigh heavily on companies' December NAVs, GPs ignore it at their peril.
The €2bn restructuring of PAI Europe V, centered around one of the world's largest ice cream makers, suggests the secondaries market may be too small.
PTP rules can prove a real pain to LPs that want to sell fund stakes. It’s worth GPs doing all they can to get around them.
Michael Slain, co-head of Investec's European Funds group, discusses the heightened need for FX hedging and how private funds can do it without breaking the bank.